Intra-Cellular Therapies ... (ITCI)
131.81
0.06 (0.05%)
At close: Mar 28, 2025, 3:59 PM
131.84
0.02%
After-hours: Mar 28, 2025, 04:21 PM EDT
Intra-Cellular Therapies Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -74.68M | -139.67M | -256.26M | -284.13M | -227.01M | -147.72M | -155.13M | -97.77M | -116.43M | -104.79M | -30.69M | -26.87M | -16.59M |
| Depreciation & Amortization | -8.52M | 528K | 656K | 533.36K | 528.12K | 477.12K | 368.67K | 213.87K | 196.87K | 139.63K | 25.48K | 23.25K | 47.75K |
| Stock-Based Compensation | 64.03M | 52.83M | 43.01M | 34.3M | 24.11M | 20.79M | 17.4M | 14.64M | 14.7M | 10.89M | 3.84M | 391.39K | 295.11K |
| Other Working Capital | -1.33M | 34.54M | 11.16M | 740.84K | -7.53M | 5.95M | 12.16M | -1.04M | 1.27M | 1.6M | 4.6M | -1.67M | -1.67M |
| Other Non-Cash Items | 82K | -8.31M | 537K | 178.53K | 214.1K | 194.21K | -529.97M | 1.06B | 233.77K | 182.6K | 176.09K | 391.39K | -2.36M |
| Deferred Income Tax | n/a | n/a | n/a | -4.08M | -648.25K | -1.13M | 529.22M | -1.06B | 544.35K | 712.67K | 297.22K | -391.39K | n/a |
| Change in Working Capital | -54.1M | -29.58M | -58.14M | -6.35M | -27.28M | -589.48K | 19.94M | 1.81M | 9.49M | -9.41M | 3.54M | 3.86M | -2.65M |
| Operating Cash Flow | -73.18M | -124.2M | -270.19M | -259.54M | -230.07M | -127.98M | -118.17M | -80.49M | -91.26M | -102.28M | -22.81M | -22.59M | -18.9M |
| Capital Expenditures | -322K | -269K | -778K | -325.74K | -266.72K | -700.39K | -391.27K | -723.43K | -48.96K | -860.6K | -11.76K | -33.26K | -38.96K |
| Acquisitions | n/a | n/a | 127.59M | -280.67M | 480.03M | -178.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -739.68M | -415.27M | -759.21M | -224.57M | -755.63M | -80.72M | -271.16M | -520.93M | -395.76M | -514.31M | -103.6M | n/a | -12M |
| Sales Maturities Of Investments | 404.85M | 521.08M | 631.61M | 505.24M | 275.6M | 258.86M | 406.19M | 428.93M | 488.07M | 153.39M | 36.88M | 1.5M | 17.7M |
| Other Investing Acitivies | n/a | n/a | -127.59M | 280.67M | -480.03M | 178.14M | 135.03M | -91.99M | 92.31M | -360.92M | -66.72M | 1.5M | 5.7M |
| Investing Cash Flow | -335.15M | 105.54M | -128.37M | 280.34M | -480.3M | 177.44M | 134.64M | -92.72M | 92.26M | -361.78M | -66.73M | 1.47M | 5.66M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | 31.08K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 24.42M | 17.81M | 21.44M | 11.52M | 11.46M | 3.24M | 685.19K | 285.16K | 477.73K | -103.27K | -475.73K | 40.53M | 15.16M |
| Financial Cash Flow | 567.51M | 17.81M | 455.16M | 11.52M | 664.18M | 3.24M | 685.19K | 162.36M | 477.73K | 449.89M | 115.72M | 40.63M | 15.19M |
| Net Cash Flow | 159.18M | -848K | 56.6M | 32.32M | -46.19M | 52.69M | 17.16M | -10.85M | 1.48M | -14.17M | 26.17M | 19.51M | 1.95M |
| Free Cash Flow | -73.5M | -124.47M | -270.96M | -259.87M | -230.34M | -128.68M | -118.56M | -81.22M | -91.31M | -103.14M | -22.82M | -22.62M | -18.94M |